glp-1 drugs pharmaceutical companies 2025 Receptor Agonist Market Size 💉 Leading The GLP-1 Revolution

Oligopeptides stimulate glucagon-like peptide-1 secretion in mice through proton-coupled uptake and the calcium-sensing receptor

doi: 10.1111/jdi.12445 12 TakedaYFujitaYYanagimachiTMaruyamaNBesshoRSakagamiHet al

GLP-1 drugs likely to be helpful for additional indications October 22, 2025 Summary: New GLP-1 and related drugs are likely to become available over the next 3-5 years, and this drug class will likely be approved for additional indications

It is not known if Wegovy will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people Do not use Wegovy if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Do not use Wegovy if: you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) you have had a serious allergic reaction to semaglutide or any of the ingredients in Wegovy injection or Wegovy tablets

De Wit HM, Vervoort GMM, Jansen HJ, De Grauw WJC, De Galan BE, Tack CJ

3 There are currently three PBS-subsidised GLP-1RAs dulaglutide, exenatide and semaglutide with different administration frequencies and devices